Haemonetics CEO Christopher Simon's 2019 pay rises 9% to $8.6M
Haemonetics reports 2019 executive compensation
By ExecPay News
Published: June 12, 2019
Haemonetics reported fiscal year 2019 executive compensation information on June 12, 2019.
In 2019, five executives at Haemonetics received on average a compensation package of $3.2M, a 5% decrease compared to previous year.
Average pay of disclosed executives at Haemonetics
Christopher Simon, Chief Executive Officer, received $8.6M in total, which increased by 9% compared to 2018. 54% of Simon's compensation, or $4.6M, was in stock awards. Simon also received $2M in non-equity incentive plan, $1.1M in option awards, $894K in salary, as well as $28K in other compensation.
For fiscal year 2019, the median employee pay was $41,811 at Haemonetics. Therefore, the ratio of Christopher Simon's pay to the median employee pay was 205 to one.
William P. Burke, Chief Financial Officer, received a compensation package of $2.3M, which increased by 15% compared to previous year. 36% of the compensation package, or $841K, was in stock awards.
Michelle L. Basil, General Counsel, earned $2.1M in 2019, a 3% increase compared to previous year.
Jacqueline D. Scanlan, Senior Vice President, Global Human Resources, received $1.5M in 2019, which increases by 5% compared to 2018.
Said Bolorforosh, Chief Technology Officer, earned $1.4M in 2019.
Haemonetics' fiscal year ends on April 2.
Related executives
You may also like
Source: SEC filing on June 12, 2019.